i think she was relating prior information -- senyak had quoted successess with pacritinib but i believe it IS still on hold.
right...that makes sense. yes, i was aware of the hold (and subsequent zhenya senyak freakout) of the pacritinib trial...for whatever reason didnt put the abbreviation together. i thought you meant "patient" or something. thanks for the clarification.
the patient was listing medications that were discussed, not saying they were studied as combo drugs. patient was not discussing trials specific to fred hutch, but rather in general "this medication is having these results, this medication is showing this promise", etc.
just put him on ignore rather than giving him so much free press. this is how we would up with Trump as a nominee.
gotta put those clowns on ignore. ive put half this board on ignore. so refreshing to see only 11 posts when i tune in to sniff out any news.
do you know if he is long or short or by what name (on YMB) he might go by?
Why would Mayo feel the need to fall in line with estimated JNJ timeline? Seems to me, they would leave the date as is and only move it up if JNJ announces approval and release of drug. Who knows if JNJ trials get delayed, FDA moves slower than expected, etc. I have to think they changed their trial for some other reason than as a tip of the hat to JNJ.
yeah...i posited something like that -- acquisition talk being posturing more than anything -- a month or two ago, so yeah, i agree with you.
and yes, need to get imetelstat approved.
...(before being bought out)?
i mean, why else would they be uncertain if there wasn't a timeline involved. because otherwise, if they were to remain independent, they could be looking forever and no reason to express uncertainty.